Tag: VBI Vaccines Inc. (NASDAQ: VBIV)

Business

VBI Vaccines Inc. (NASDAQ: VBIV) Surges 14.45% Following Fast Track Designation For VBI-1901

VBI Vaccines Inc. (NASDAQ: VBIV) stock gained 14.45% after the company announced that the FDA had granted its VBI-1901 cancer vaccine immunotherapeutic candidate a Fast track Designation for the treatment of recurrent glioblastoma patients with first tumor recurrence. Fast Track Designation speeds up developing and reviewing innovative treatments to cure […]